- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03098914
Clinical Characteristics and Microbiology of Community-Acquired Pneumonia
April 3, 2017 updated by: Liu chao, Beijing Haidian Hospital
Clinical Characteristics and Microbiology of Community-Acquired Pneumonia: A Prospective Study
Community-Acquired Pneumonia has become common.
Additionally, the mortality is high.
But the epidemiology of pathogen is various in different areas, which is crucial for the key treatment.
In addition, the risk factors of patients who died in 3 or 7 days in china is not clear, comparing with patients who died in 14 or 28 days or who survived.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
2000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100000
- Recruiting
- Beijing Haidian Hospital
-
Contact:
- Liu Chao, Master
- Phone Number: +86 18614043137
- Email: liuchao3619@163.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
patients with commnuity acquired pneumonia
Description
Inclusion Criteria:
- Confirmed community acquired pneumonia
- Age≥18 ys
Exclusion Criteria:
- HIV infection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Beijing Haidian Hospital
|
Cohort Study; pathogen; clinical features
|
Chinese PLA General Hospital
|
Cohort Study; pathogen; clinical features
|
Beijing Tsinghua Chang gung Hospital
|
Cohort Study; pathogen; clinical features
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the epidemiology of pathogen of community-acquired pneumonia in the three hospitals
Time Frame: confirmed as community-acquired pneumonia (2 weeks)
|
screen out the pathogen of community-acquired pneumonia
|
confirmed as community-acquired pneumonia (2 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
risk factors of patients who died in 3 or 7 days
Time Frame: in one week(3 days or 7days)
|
patients who die in 3 or 7 days
|
in one week(3 days or 7days)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
April 11, 2017
Primary Completion (Anticipated)
April 1, 2019
Study Completion (Anticipated)
May 1, 2019
Study Registration Dates
First Submitted
March 22, 2017
First Submitted That Met QC Criteria
March 31, 2017
First Posted (Actual)
April 4, 2017
Study Record Updates
Last Update Posted (Actual)
April 5, 2017
Last Update Submitted That Met QC Criteria
April 3, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Beijing Haidian Hospital
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Community-acquired Pneumonia
-
GlaxoSmithKlineTerminated
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineTerminated
-
GlaxoSmithKlineCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
University Medical Centre LjubljanaUniversity of Ljubljana, Faculty of MedicineUnknownCommunity Acquired Pneumonia | Ventilator Associated Pneumonia | Hospital Acquired PneumoniaSlovenia
-
Basilea PharmaceuticaCompletedCommunity-acquired Pneumonia (CAP) | Hospital-acquired Pneumonia (HAP)Bulgaria, Hungary, Georgia, Romania
-
Liverpool University Hospitals NHS Foundation TrustLiverpool School of Tropical MedicineCompletedCommunity Acquired Pneumonia | Lower Respiratory Tract Infection | Hospital Acquired PneumoniaUnited Kingdom
-
Future University in EgyptRecruitingCommunity-acquired PneumoniaEgypt
-
Nordsjaellands HospitalRecruitingCommunity-acquired PneumoniaDenmark
Clinical Trials on Cohort Study; pathogen; clinical features
-
Central Hospital, Nancy, FranceNot yet recruitingAlzheimer Disease | Homocystinemia
-
Tianjin Medical University Cancer Institute and...Tianjin Chest HospitalRecruitingSquamous Cell Carcinoma | Lung Neoplasm | ExosomesChina
-
Institute of Biomedical Technologies-National Research...University of Milan; National Research Council, Institute of Clinical Physiology... and other collaboratorsCompletedCovid19 | SARS-CoV Infection | Epidemic Disease | Self-Assessment | Survey, Family LifeItaly
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
Istituto Ortopedico RizzoliCompleted
-
Vanderbilt University Medical CenterRecruitingCovid19 | Pulmonary Fibrosis | Sars-CoV-2 Infection | COVID-19 Acute Respiratory Distress Syndrome | Dyspnea Caused by 2019-nCoVUnited States
-
Hannover Medical SchoolUnknownCommunity Acquired PneumoniaGermany
-
Samsung Medical CenterCytoGen, Inc.; UNIST (Ulsan National Institute of Science and Technology)Active, not recruitingNSCLC Stage IV | NSCLC Stage IIIBKorea, Republic of
-
European Foundation for the Care of Newborn InfantsRespiratory Syncytial Virus Foundation (ReSViNET); European Society for Paediatric... and other collaboratorsRecruitingQuality of Life | Caregiver Burden | Infant ALL | RSV Infection | FamilyGermany
-
Lawson Health Research InstituteRecruitingKnee Osteoarthritis | Hip OsteoarthritisCanada